West Pharmaceutical Services IncNYSE:WST
- LAST PRICE317.7500
- TODAY'S CHANGE (%)-2.0400 (-0.6379%)
- Bid / Lots317.7400/ 1
- Ask / Lots318.3300/ 7
- Open / Previous Close320.2600 / 319.7900
- Day Range
- 52 Week Range
- Volume112,386
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | WST |
|---|---|---|
| 09:32 ET | 4913 | 318.53 |
| 09:33 ET | 300 | 318.21 |
| 09:39 ET | 100 | 318.005 |
| 09:48 ET | 1062 | 316.11 |
| 09:50 ET | 100 | 315.31 |
| 09:51 ET | 300 | 316.11 |
| 09:53 ET | 100 | 317.075 |
| 10:00 ET | 701 | 315.275 |
| 10:02 ET | 1535 | 315.43 |
| 10:04 ET | 4245 | 316.81 |
| 10:06 ET | 108 | 316.46 |
| 10:08 ET | 400 | 316.33 |
| 10:13 ET | 100 | 317.39 |
| 10:15 ET | 100 | 317.35 |
| 10:18 ET | 380 | 316.97 |
| 10:20 ET | 100 | 317.77 |
| 10:22 ET | 1803 | 317.785 |
| 10:24 ET | 300 | 317.705 |
| 10:26 ET | 233 | 317.15 |
| 10:27 ET | 291 | 315.9142 |
| 10:33 ET | 593 | 315.24 |
| 10:36 ET | 100 | 316.095 |
| 10:38 ET | 100 | 315.37 |
| 10:40 ET | 1019 | 315.665 |
| 10:42 ET | 520 | 316.515 |
| 10:44 ET | 100 | 316.59 |
| 10:45 ET | 800 | 315.92 |
| 10:47 ET | 100 | 315.33 |
| 10:49 ET | 100 | 315.72 |
| 10:51 ET | 100 | 315.755 |
| 10:56 ET | 628 | 317.0523 |
| 10:58 ET | 550 | 315.17 |
| 11:03 ET | 100 | 316.015 |
| 11:07 ET | 100 | 315.63 |
| 11:09 ET | 2102 | 316.485 |
| 11:12 ET | 4412 | 316.94 |
| 11:14 ET | 4598 | 317.625 |
| 11:16 ET | 12496 | 317.5 |
| 11:18 ET | 200 | 317.5 |
| 11:20 ET | 300 | 317.47 |
| 11:21 ET | 296 | 317.33 |
| 11:32 ET | 100 | 318.25 |
| 11:34 ET | 100 | 318.4 |
| 11:36 ET | 500 | 318.37 |
| 11:38 ET | 200 | 318.915 |
| 11:39 ET | 3009 | 318.835 |
| 11:41 ET | 1774 | 319 |
| 11:43 ET | 500 | 318.925 |
| 11:59 ET | 247 | 319.45 |
| 12:01 ET | 100 | 319.14 |
| 12:03 ET | 100 | 318.76 |
| 12:06 ET | 200 | 318.665 |
| 12:08 ET | 327 | 318.34 |
| 12:10 ET | 100 | 318.43 |
| 12:14 ET | 100 | 318.18 |
| 12:15 ET | 400 | 318.45 |
| 12:19 ET | 100 | 318.285 |
| 12:21 ET | 100 | 318.405 |
| 12:26 ET | 605 | 317.93 |
| 12:32 ET | 439 | 318.64 |
| 12:37 ET | 406 | 318.285 |
| 12:42 ET | 200 | 317.75 |
Oct 29, 2024
West to Participate in Upcoming Investor Conferences, from 6:00AM ET on Tuesday Oct 29, 2024 by Dow Jones
6:00AM ET on Tuesday Oct 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
West Pharmaceutical Services Inc | 22.9B | 47.1x | +23.79% |
Cooper Companies Inc | 20.1B | 56.6x | -3.70% |
STERIS plc | 21.2B | 35.2x | +9.33% |
Zimmer Biomet Holdings Inc | 21.9B | 21.0x | --- |
Insulet Corp | 18.4B | 46.3x | +122.51% |
Dexcom Inc | 28.4B | 47.3x | --- |
Company Information
West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates through two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers packaging, containment solutions, and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
Contact Information
- Headquarters
- 530 Herman O. West DriveEXTON, PA, United States 19341
- Phone
- 610-594-2900
- Fax
- 800-345-9800
Executives
- Chairman of the Board, President, Chief Executive Officer
- Eric Green
- Chief Financial Officer
- Bernard Birkett
- Chief Human Resource Officer, Senior Vice President
- Annette Favorite
- Senior Vice President, Chief Technology Officer
- Silji Abraham
- Senior Vice President, General Counsel, Corporate Secretary
- Kimberly Mackay
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $22.9B |
|---|---|
Revenue (TTM) | $2.9B |
Shares Outstanding | 72.4M |
Dividend Yield | 0.26% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 11-13-24 |
Pay Date | 11-20-24 |
Beta | 1.00 |
EPS | $6.75 |
Book Value | $39.20 |
P/E Ratio | 47.1x |
Price/Sales (TTM) | 8.0 |
Price/Cash Flow (TTM) | 36.2x |
Operating Margin | 19.86% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
